Drug Type Small molecule drug |
Synonyms ON 108600, ON108600 |
Target |
Mechanism CK2 inhibitors(Casein kinase II inhibitors), TNIK inhibitors(TRAF2 and NCK-interacting protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | US | 01 Aug 2015 | |
Triple Negative Breast Cancer | Preclinical | US | 01 Aug 2015 |